At the news
? NEUTRALIMPACT 4/10 SC 13G filed Nov 16, 2026 at 14:13 ET
Armistice Capital filed a new Schedule 13G disclosing a 9.79% passive stake in Treace Medical Concepts as of September 30, 2026, up from 1.96% in its prior filing. This marks a significant re-accumulation by a former top holder after reducing below 5% earlier in the year.
- Armistice Capital disclosed beneficial ownership of 6,364,000 shares of Treace Medical Concepts common stock.
- The stake represents 9.79% of shares outstanding as of September 30, 2026.
- This is a new Schedule 13G filing, not an amendment, indicating a new 5%+ position.
- The filing certifies passive intent under Rule 13d-1(b), with no control influence purpose.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access